Grifols Covid

The objective of this study is to evaluate the safety and efficacy of liquid alpha-proteinase inhibitor versus placebo in subjects with Covid-19. Patient must be admitted to hospital with a confirmed positive COVID result.
Contact phone
517..36.4.5760
Principal investigator
Dr. Jennifer Ely, D.O.
Trial Category
Pulmonary
Trial SubCategory
Covid
Webform